Δημοσίευση

Association of NFKB1 -94ATTG ins/del polymorphism (rs28362491) with pemphigus vulgaris.

ΤίτλοςAssociation of NFKB1 -94ATTG ins/del polymorphism (rs28362491) with pemphigus vulgaris.
Publication TypeJournal Article
Year of Publication2019
AuthorsChatzikyriakidou, A., Kyriakou A., Meltzanidou P., Lambropoulos A., & Patsatsi A.
JournalExp Dermatol
Volume28
Issue8
Pagination972-975
Date Published2019 08
ISSN1600-0625
Λέξεις κλειδιάAdolescent, Adult, Aged, Aged, 80 and over, Case-Control Studies, Female, Humans, Interleukin-1 Receptor-Associated Kinases, Male, Middle Aged, NF-kappa B p50 Subunit, NF-KappaB Inhibitor alpha, Pemphigus, Polymorphism, Genetic, Young Adult
Abstract

Pemphigus vulgaris is a rare chronic blistering skin disease resulting from IgG autoantibodies directed against transmembrane desmosomal glycoprotein desmoglein 3 and is the most common form of pemphigus. Since interleukin-1 receptor-associated kinase (IRAK-1)/nuclear factor-kappa B (NF-kappa B) pathway plays an essential role in the pathogenesis of autoimmune diseases, the aim of the present study was to explore the role of polymorphisms in three genes, named IRAK1 (rs3027898), NFKBIA (rs696) and NFKB1 (-94ATTG insertion/deletion variant, - rs28362491), in PV susceptibility. Forty-four unrelated patients with PV (23 males) were enrolled in the study. Additionally, 77 ethnic matching healthy volunteers (45 males) with no personal or family history of chronic autoimmune or infectious diseases were studied. Strong statistical significant difference was observed between PV patients and controls for polymorphism -94 insertion/deletion ATTG in the promoter region of NFKB1 gene (P = 0.00005). Additional dedicated studies in larger groups of patients of various ethnicities are needed to replicate and confirm the preliminary findings.

DOI10.1111/exd.13957
Alternate JournalExp Dermatol
PubMed ID31077459

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.